Literature DB >> 16614631

Case files from the Bellevue Hospital Center at New York University--lipoatrophy following long-term antiretroviral therapy.

Demetre Daskalakis1, Judith A Aberg.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16614631      PMCID： PMC1681696     

Source DB:  PubMed          Journal:  MedGenMed        ISSN： 1531-0132


× No keyword cloud information.
  15 in total

1.  Risk factors for the HIV-associated lipodystrophy syndrome in a closed cohort of patients after 3 years of antiretroviral treatment.

Authors:  S Mauss; M Corzillius; E Wolf; A Schwenk; A Adam; H Jaeger; H Knechten; J Goelz; A Goetzenich
Journal:  HIV Med       Date:  2002-01       Impact factor: 3.180

Review 2.  Clinical review 153: Lipodystrophy in human immunodeficiency virus-infected patients.

Authors:  Dali Chen; Anoop Misra; Abhimanyu Garg
Journal:  J Clin Endocrinol Metab       Date:  2002-11       Impact factor: 5.958

3.  Medication therapy among intravenous drug users (IDUs) with HIV infection.

Authors:  P C Smith; J B Page
Journal:  AIDS Patient Care STDS       Date:  1996-04       Impact factor: 5.078

4.  The impact of the M184V substitution in HIV-1 reverse transcriptase on treatment response.

Authors:  V Miller; T Stark; A E Loeliger; J M A Lange
Journal:  HIV Med       Date:  2002-04       Impact factor: 3.180

5.  Injecting drug users' adherence to HIV antiretroviral treatments: physicians' beliefs.

Authors:  N Escaffre; M Morin; A D Bouhnik; J G Fuzibet; J A Gastaut; Y Obadia; J P Moatti
Journal:  AIDS Care       Date:  2000-12

Review 6.  The impact of the M184V substitution on drug resistance and viral fitness.

Authors:  Mark A Wainberg
Journal:  Expert Rev Anti Infect Ther       Date:  2004-02       Impact factor: 5.091

7.  Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users.

Authors:  Evan Wood; Julio S G Montaner; Benita Yip; Mark W Tyndall; Martin T Schechter; Michael V O'Shaughnessy; Robert S Hogg
Journal:  CMAJ       Date:  2003-09-30       Impact factor: 8.262

8.  A cohort study of drug users' compliance with zidovudine treatment.

Authors:  B Broers; A Morabia; B Hirschel
Journal:  Arch Intern Med       Date:  1994-05-23

9.  Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study.

Authors:  Allison Martin; Don E Smith; Andrew Carr; Clare Ringland; Janaki Amin; Sean Emery; Jennifer Hoy; Cassy Workman; Nicholas Doong; Judith Freund; David A Cooper
Journal:  AIDS       Date:  2004-04-30       Impact factor: 4.177

10.  Improvement in lipoatrophy associated with highly active antiretroviral therapy in human immunodeficiency virus-infected patients switched from stavudine to abacavir or zidovudine: the results of the TARHEEL study.

Authors:  Grace A McComsey; Douglas J Ward; Siegrid M Hessenthaler; Michael G Sension; Peter Shalit; J Tyler Lonergan; Robin L Fisher; Vanessa C Williams; Jaime E Hernandez
Journal:  Clin Infect Dis       Date:  2003-12-18       Impact factor: 9.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.